A Study of the Safety & Efficacy of UHE-105 Shampoo in Subjects With Scalp

See also
Status	Clinical Trial	Phase
Completed	`NCT00400725` - Maintenance Effect of Clobex Shampoo on Participants With Moderate to Severe Scalp Psoriasis	Phase 3
Completed	`NCT01195831` - Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis	Phase 3
Completed	`NCT03880357` - To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis	Phase 1
Completed	`NCT03331523` - To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis	Phase 3
Completed	`NCT04801433` - Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis	N/A
Completed	`NCT01120223` - Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis	Phase 2
Completed	`NCT03897088` - Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis	Phase 3
Completed	`NCT02932462` - Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis	Phase 3
Completed	`NCT02933866` - Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis	Phase 3
Completed	`NCT05872256` - A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis	Phase 4
Active, not recruiting	`NCT05272150` - Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis	Phase 3
Completed	`NCT02933502` - Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product	Phase 2
Completed	`NCT01052467` - Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)	N/A
Recruiting	`NCT02749656` - Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis	Phase 3
Completed	`NCT02078297` - IL-17 Role in Variants of Psoriasis	N/A
Completed	`NCT00438399` - Subject Preference for Scalp Psoriasis Treatment	Phase 3
Completed	`NCT05028582` - Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)	Phase 3
Completed	`NCT01914627` - Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis	Phase 2
Not yet recruiting	`NCT01558310` - A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis	Phase 4
Recruiting	`NCT05969223` - Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis	Phase 4

NCT number	NCT04243486
Study type	Interventional
Source	Therapeutics, Inc.
Contact
Status	Completed
Phase	Phase 2
Start date	January 2, 2020
Completion date	June 15, 2020

A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms